Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Advancing Mesenchymal Stem Cell Therapy With Crispr/Cas9 for Clinical Trial Studies Publisher Pubmed



Golchin A1, 2 ; Shams F3 ; Karami F2
Authors

Source: Advances in Experimental Medicine and Biology Published:2020


Abstract

Currently, regenerative medicine and cellular-based therapy have been in the center of attention worldwide in advanced medical technology. Mesenchymal stem cell (MSC) as a suitable stem cell source for cell-based therapy has been shown to be safe and effective in multiple clinical trial studies (CTSs) of several diseases. Despite the advantages, MSC needs more investigation to enhance its therapeutic application. The CRISPR/Cas system is a novel technique for editing of genes that is being explored as a means to improve MSCs therapeutic usage. In this study, we review the recent studies that explore CRISPR potency in gene engineering of MSCs, which have great relevance in MSC-based therapies. However, CRISPR/Cas technology make possible specific targeting of loci in target genes, but next-generation MSC-based therapies to achieve extensive clinical application need dedicated efforts. © Springer Nature Switzerland AG 2019.
Related Docs
View other Related Docs
1. Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations, Biomedicine and Pharmacotherapy (2022)
2. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)
3. Crispr Pioneers Win 2020 Nobel Prize for Chemistry, Iranian Journal of Public Health (2020)
Experts (# of related papers)
View all Related Experts
Mohammad Vasei (1)
Nima Rezaei (1)
Other Related Docs
4. Implications of Crispr-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases, Current Problems in Cardiology (2023)
5. Technology Developments in Biological Tools for Targeted Genome Surgery, Biotechnology Letters (2015)
6. The Clinical Trials of Mesenchymal Stromal Cells Therapy, Stem Cells International (2021)
7. Targeting Mrna-Coding Genes in Prostate Cancer Using Crispr/Cas9 Technology With a Special Focus on Androgen Receptor Signaling, Cell Communication and Signaling (2024)
8. Highly Photoluminescent Nitrogen- and Zinc-Doped Carbon Dots for Efficient Delivery of Crispr/Cas9 and Mrna, Bioconjugate Chemistry (2021)
9. The Bilayer Skin Substitute Based on Human Adipose-Derived Mesenchymal Stem Cells and Neonate Keratinocytes on the 3D Nanofibrous Pcl-Platelet Gel Scaffold, Polymer Bulletin (2022)
10. Biological Products: Cellular Therapy and Fda Approved Products, Stem Cell Reviews and Reports (2019)
11. Pipeline for the Generation of Gene Knockout Mice Using Dual Sgrna Crispr/Cas9-Mediated Gene Editing, Analytical Biochemistry (2019)
12. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
13. Stem Cell Therapy Potency in Personalizing Severe Covid-19 Treatment, Stem Cell Reviews and Reports (2021)
14. The Trend of Crispr-Based Technologies in Covid-19 Disease: Beyond Genome Editing, Molecular Biotechnology (2023)
15. Crispr Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential, Cell Proliferation (2025)
16. Crispr/Cas9 Revitalizes Adoptive T-Cell Therapy for Cancer Immunotherapy, Journal of Experimental and Clinical Cancer Research (2021)
17. The Crispr Growth Spurt: From Bench to Clinic on Versatile Small Rnas, Journal of Microbiology and Biotechnology (2017)
18. Genetic Advancements in Breast Cancer Treatment: A Review, Discover Oncology (2025)
19. Crispr-Cas9 in Basic and Translational Aspects of Cancer Therapy, BioImpacts (2024)
20. Clinical Applications of the Crispr/Cas9 Genome-Editing System: Delivery Options and Challenges in Precision Medicine, Genes and Diseases (2024)